About immunocore holdings - IMCR
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
IMCR At a Glance
Immunocore Holdings Plc
92 Park Drive
Abingdon, Oxfordshire OX14 4RY
| Phone | 44-1235-438600 | Revenue | 310.33M | |
| Industry | Biotechnology | Net Income | -51,108,496.83 | |
| Sector | Health Technology | 2024 Sales Growth | 23.937% | |
| Fiscal Year-end | 12 / 2025 | Employees | 493 | |
| View SEC Filings |
IMCR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 4.752 |
| Price to Book Ratio | 4.118 |
| Price to Cash Flow Ratio | 56.56 |
| Enterprise Value to EBITDA | -16.40 |
| Enterprise Value to Sales | 3.503 |
| Total Debt to Enterprise Value | 0.398 |
IMCR Efficiency
| Revenue/Employee | 629,477.747 |
| Income Per Employee | -103,668.351 |
| Receivables Turnover | 3.735 |
| Total Asset Turnover | 0.386 |
IMCR Liquidity
| Current Ratio | 4.382 |
| Quick Ratio | 4.357 |
| Cash Ratio | 3.866 |
IMCR Profitability
| Gross Margin | 97.764 |
| Operating Margin | -22.715 |
| Pretax Margin | -17.065 |
| Net Margin | -16.469 |
| Return on Assets | -6.363 |
| Return on Equity | -14.011 |
| Return on Total Capital | -6.441 |
| Return on Invested Capital | -8.221 |
IMCR Capital Structure
| Total Debt to Total Equity | 119.962 |
| Total Debt to Total Capital | 54.538 |
| Total Debt to Total Assets | 42.865 |
| Long-Term Debt to Equity | 119.533 |
| Long-Term Debt to Total Capital | 54.343 |